Becca Stanek is an experienced writer and editor who is passionate about exploring the ways we can feel better mentally and physically to get the most out of our lives. She has worked for publications ...
Angela Myers is a freelance writer covering mental health, wellness and nutrition. She’s also conducted award-winning research on how to better communicate about sexual violence prevention and mental ...
The MarketWatch News Department was not involved in the creation of this content. ALPHARETTA, Ga., Aug. 19, 2025 /PRNewswire/ -- Alora Pharmaceuticals, LLC, the parent company of Vertical ...
Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a generic version of Janssen's Concerta® ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY), an integrated pharmaceutical company, announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg ...
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) on Tuesday proposed withdrawing two generic versions of Janssen’s extended-release attention deficit ...
* Mylan - U.S. launch of methylphenidate hydrochloride extended-release tablets usp, 18 mg, 27 mg, 36 mg and 54 mg, generic version of Janssen's Concerta tablets Source text for Eikon: Further company ...
US regulatory officials say they have identified not one but two supposed generic copies of the attention deficit hyperactive disorder (ADHD) treatment drug Concerta that have failed to demonstrate ...
TOKYO -- A shortage of Concerta, a leading medication for attention-deficit/hyperactivity disorder (ADHD), has forced doctors to temporarily halt new prescriptions ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
A head-to-head trial of ADHD treatments finds dexamphetamine and methylphenidate equally effective, with notable differences ...